Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases

Beatrice Goilav, Lisa M. Satlin, Patricia D. Wilson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of end-stage renal disease in adults. Autosomal recessive (AR) PKD affects ∼1:20,000 live-born children with high perinatal mortality. Both diseases have abnormalities in epithelial proliferation, secretion, and cell-matrix interactions, leading to progressive cystic expansion and associated interstitial fibrosis. Cell number in a kidney reflects the balance between proliferation and apoptosis. Apoptosis results from extrinsic (ligand-induced, expression of caspase-8) and intrinsic (mitochondrial damage, expression of caspase-9) triggers. Previous studies have suggested a role for apoptosis in PKD cyst formation and parenchymal destruction. Mechanisms underlying apoptosis in human ADPKD and ARPKD were examined by quantitative immunohistochemistry and Western immunoblot analyses of age-matched normal and PKD tissues. Caspase-8 expression was significantly greater in small cysts and normal-appearing tubules than in larger cysts in ADPKD kidneys. Caspase-8 also appeared early in the disease process of ADPKD. In ARPKD, expression of caspase-8 was most pronounced in later stages of the disease and was not confined to a specific cyst size. In conclusion, apoptosis in human ADPKD is an early event, occurring predominantly in normal-appearing tubules and small cysts, and is triggered by an extrinsic factor, but it occurs later in ARPKD.

Original languageEnglish (US)
Pages (from-to)1473-1482
Number of pages10
JournalPediatric Nephrology
Volume23
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Autosomal Dominant Polycystic Kidney
Autosomal Recessive Polycystic Kidney
Caspase 8
Cysts
Apoptosis
Kidney
Caspase 9
Perinatal Mortality
Cell Communication
Chronic Kidney Failure
Fibrosis
Cell Count
Western Blotting
Immunohistochemistry
Ligands

Keywords

  • Apoptosis
  • Autosomal dominant polycystic kidney disease
  • Autosomal recessive polycystic kidney disease
  • Caspase
  • Extrinsic pathway

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases. / Goilav, Beatrice; Satlin, Lisa M.; Wilson, Patricia D.

In: Pediatric Nephrology, Vol. 23, No. 9, 09.2008, p. 1473-1482.

Research output: Contribution to journalArticle

@article{4156578773db43d297950a0da56ff7d7,
title = "Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases",
abstract = "Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of end-stage renal disease in adults. Autosomal recessive (AR) PKD affects ∼1:20,000 live-born children with high perinatal mortality. Both diseases have abnormalities in epithelial proliferation, secretion, and cell-matrix interactions, leading to progressive cystic expansion and associated interstitial fibrosis. Cell number in a kidney reflects the balance between proliferation and apoptosis. Apoptosis results from extrinsic (ligand-induced, expression of caspase-8) and intrinsic (mitochondrial damage, expression of caspase-9) triggers. Previous studies have suggested a role for apoptosis in PKD cyst formation and parenchymal destruction. Mechanisms underlying apoptosis in human ADPKD and ARPKD were examined by quantitative immunohistochemistry and Western immunoblot analyses of age-matched normal and PKD tissues. Caspase-8 expression was significantly greater in small cysts and normal-appearing tubules than in larger cysts in ADPKD kidneys. Caspase-8 also appeared early in the disease process of ADPKD. In ARPKD, expression of caspase-8 was most pronounced in later stages of the disease and was not confined to a specific cyst size. In conclusion, apoptosis in human ADPKD is an early event, occurring predominantly in normal-appearing tubules and small cysts, and is triggered by an extrinsic factor, but it occurs later in ARPKD.",
keywords = "Apoptosis, Autosomal dominant polycystic kidney disease, Autosomal recessive polycystic kidney disease, Caspase, Extrinsic pathway",
author = "Beatrice Goilav and Satlin, {Lisa M.} and Wilson, {Patricia D.}",
year = "2008",
month = "9",
doi = "10.1007/s00467-008-0851-9",
language = "English (US)",
volume = "23",
pages = "1473--1482",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases

AU - Goilav, Beatrice

AU - Satlin, Lisa M.

AU - Wilson, Patricia D.

PY - 2008/9

Y1 - 2008/9

N2 - Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of end-stage renal disease in adults. Autosomal recessive (AR) PKD affects ∼1:20,000 live-born children with high perinatal mortality. Both diseases have abnormalities in epithelial proliferation, secretion, and cell-matrix interactions, leading to progressive cystic expansion and associated interstitial fibrosis. Cell number in a kidney reflects the balance between proliferation and apoptosis. Apoptosis results from extrinsic (ligand-induced, expression of caspase-8) and intrinsic (mitochondrial damage, expression of caspase-9) triggers. Previous studies have suggested a role for apoptosis in PKD cyst formation and parenchymal destruction. Mechanisms underlying apoptosis in human ADPKD and ARPKD were examined by quantitative immunohistochemistry and Western immunoblot analyses of age-matched normal and PKD tissues. Caspase-8 expression was significantly greater in small cysts and normal-appearing tubules than in larger cysts in ADPKD kidneys. Caspase-8 also appeared early in the disease process of ADPKD. In ARPKD, expression of caspase-8 was most pronounced in later stages of the disease and was not confined to a specific cyst size. In conclusion, apoptosis in human ADPKD is an early event, occurring predominantly in normal-appearing tubules and small cysts, and is triggered by an extrinsic factor, but it occurs later in ARPKD.

AB - Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of end-stage renal disease in adults. Autosomal recessive (AR) PKD affects ∼1:20,000 live-born children with high perinatal mortality. Both diseases have abnormalities in epithelial proliferation, secretion, and cell-matrix interactions, leading to progressive cystic expansion and associated interstitial fibrosis. Cell number in a kidney reflects the balance between proliferation and apoptosis. Apoptosis results from extrinsic (ligand-induced, expression of caspase-8) and intrinsic (mitochondrial damage, expression of caspase-9) triggers. Previous studies have suggested a role for apoptosis in PKD cyst formation and parenchymal destruction. Mechanisms underlying apoptosis in human ADPKD and ARPKD were examined by quantitative immunohistochemistry and Western immunoblot analyses of age-matched normal and PKD tissues. Caspase-8 expression was significantly greater in small cysts and normal-appearing tubules than in larger cysts in ADPKD kidneys. Caspase-8 also appeared early in the disease process of ADPKD. In ARPKD, expression of caspase-8 was most pronounced in later stages of the disease and was not confined to a specific cyst size. In conclusion, apoptosis in human ADPKD is an early event, occurring predominantly in normal-appearing tubules and small cysts, and is triggered by an extrinsic factor, but it occurs later in ARPKD.

KW - Apoptosis

KW - Autosomal dominant polycystic kidney disease

KW - Autosomal recessive polycystic kidney disease

KW - Caspase

KW - Extrinsic pathway

UR - http://www.scopus.com/inward/record.url?scp=47749124551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47749124551&partnerID=8YFLogxK

U2 - 10.1007/s00467-008-0851-9

DO - 10.1007/s00467-008-0851-9

M3 - Article

VL - 23

SP - 1473

EP - 1482

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 9

ER -